Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Recruiting

Phase 2

BHV-7000Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Sponsor:

Biohaven Therapeutics Ltd.

Code:

NCT06419608

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BHV-7000

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by Biohaven Therapeutics Ltd. on 2025-05-22.